上肢纤维肌性发育不良的临床表现与干预转归:22例病例系列
本病例系列来自两个三级转诊中心,纳入22例(29条患肢)上肢纤维肌性发育不良患者,分析临床表现、诊断方法与干预结局。最常见受累血管为肱动脉(89.7%),超过半数患肢无症状;有症状患肢首次干预以药物治疗为主,仅28.6%获得完全症状缓解。
要点
- 肱动脉最常受累(89.7%患肢),超过半数患肢无症状
- 有症状患肢首次干预以药物治疗为主(57.1%)
- 仅28.6%有症状患肢首次干预后完全缓解,部分需二次干预
核心结论
- 上肢纤维肌性发育不良表现从无症状到指端缺血不等,超过半数有症状患肢最终需至少一次侵入性干预才能完全缓解症状。
研究设计与样本
- 两中心病例系列,纳入22例(29条患肢)上肢纤维肌性发育不良患者,收集人口学、症状、受累动脉、FMD类型、诊断方法、查体、治疗与结局。
主要发现
- 肱动脉最常受累,占89.7%患肢。
- 15/29条患肢(51.7%)无症状;有症状者以指/手缺血(31%患肢)和手/臂跛行(27.6%患肢)最常见。
- 导管造影诊断58.6%(17/29患肢),双功能超声41.4%(12/29患肢),CT血管造影27.6%(8/29患肢)。
- 14条有症状患肢中57.1%首选单纯药物治疗;接受血管干预的5条患肢以血管成形术最常用。
- 首次干预后仅4/14条患肢(28.6%)完全缓解;10条残留症状患肢中6条接受二次干预,二次手术旁路和血管成形术均获完全缓解。
关键数值与推荐
- 有症状患肢(n=14)首次干预:57.1%仅药物治疗。
- 首次干预后完全症状缓解4/14条患肢(28.6%)。
- 二次干预:药物治疗后血管成形术2条(33.3%),血管成形术后手术旁路2条,药物治疗后手术旁路1条,血管成形术后交感神经切除术1条(16.7%)。
临床怎么用
- 对上肢缺血或跛行患者应考虑FMD可能,导管造影和双功能超声是常用诊断方法。
- 有症状患肢可先尝试药物治疗,但需告知完全缓解率有限,部分需二次血管干预。
局限性
- 两中心回顾性病例系列,样本量小(22例29条患肢),结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We present a case series of upper extremity fibromuscular dysplasia (UE FMD) consisting of 22 patients from two tertiary referral centers focusing on clinical presentation, diagnostic findings, and interventional outcomes. FMD is a noninflammatory, nonatherosclerotic arteriopathy that has a predisposition for middle-aged women. Involvement of the UE is thought to be rare. Patients with UE FMD can present with claudication or ischemia, or they can be incidentally diagnosed. The treatment approach is dictated by clinical presentation. METHODS: Data were collected of patients with UE FMD evaluated at two centers. Demographic data, presenting UE symptoms, UE arteries involved, FMD type, diagnostic method, physical examination findings, management, and outcomes were included. RESULTS: Twenty-two patients (29 limbs) were diagnosed with UE FMD. The brachial artery was most commonly involved (89.7% of affected limbs). More than half of limbs (n = 15 of 29 limbs [51.7%]) were asymptomatic, and of those who presented with symptoms, the most common symptoms were ischemic fingers or hand (31% of all affected limbs) and hand or arm claudication (27.6% of all affected limbs). UE FMD was noted on catheter angiography in 58.6% (n = 17 of 29 limbs), duplex ultrasound in 41.4% (n = 12 of 29 limbs), and computed tomography angiography in 27.6% (n = 8 of 29 limbs). Of the symptomatic limbs (n = 14), the majority were treated solely with medical therapy as the first intervention (57.1%). For symptomatic limbs treated with vascular intervention (n = 5), angioplasty was most commonly performed. Only 4 of the 14 limbs (28.6%) had complete symptomatic relief after the initial first intervention, in which 2 limbs were treated with medical therapy, 1 limb underwent angioplasty, and 1 limb had resolution of symptoms despite deferment of any therapy. Of the 10 limbs with residual symptoms after the first intervention, 6 limbs underwent a second intervention: angioplasty in 2 limbs initially treated medically (33.3%), surgical bypass in 2 limbs initially treated with angioplasty, surgical bypass in 1 limb initially treated with medical therapy, and sympathectomy in 1 limb (16.7%) initially treated with angioplasty. Both surgical bypass and angioplasty as secondary interventions resulted in complete symptom relief. CONCLUSIONS: Presenting symptoms for patients with UE FMD vary in severity from asymptomatic disease to digital ischemia. More than half of symptomatic limbs eventually require at least one invasive intervention for complete relief of symptoms.
引用
- Nguyen N, Sharma A, West JK, et al. Presentation, clinical features, and results of intervention in upper extremity fibromuscular dysplasia. J Vasc Surg. 2017. PMID: 28735951. doi:10.1016/j.jvs.2017.02.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。